Cargando…
Effect of Gastric Bypass Surgery on the Absorption and Bioavailability of Metformin
OBJECTIVE: Use of gastric bypass surgery is common and increasing. Over 40% of patients in diabetes remission after gastric bypass surgery may redevelop diabetes within 5 years. Metformin, the first-line drug for diabetes, has low bioavailability and slow, incomplete gastrointestinal absorption. We...
Autores principales: | Padwal, Raj S., Gabr, Raniah Q., Sharma, Arya M., Langkaas, Lee-Ann, Birch, Dan W., Karmali, Shahzeer, Brocks, Dion R. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Diabetes Association
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3114332/ https://www.ncbi.nlm.nih.gov/pubmed/21478461 http://dx.doi.org/10.2337/dc10-2140 |
Ejemplares similares
-
Metformin and Exercise in Type 2 Diabetes: Examining treatment modality interactions
por: Boulé, Normand G., et al.
Publicado: (2011) -
The Alberta population-based prospective evaluation of the quality of life outcomes and economic impact of bariatric surgery (APPLES) study: background, design and rationale
por: Padwal, Raj S, et al.
Publicado: (2010) -
Health status, quality of life, and satisfaction of patients awaiting multidisciplinary bariatric care
por: Padwal, Raj S, et al.
Publicado: (2012) -
Comparing Patient Selection and 30-day Outcomes Between Single Anastomosis Gastric Bypass and Roux-en-Y Gastric Bypass: a Retrospective Cohort Study of 47,384 Patients
por: Mocanu, Valentin, et al.
Publicado: (2022) -
Endoscopic Treatment Options in Patients With Gastrojejunal Anastomosis Stricture Following Roux-en-Y Gastric Bypass
por: Gill, Richdeep S., et al.
Publicado: (2012)